Key Takeaways: Two new CRISPR-based strategies offer hope for next-generation Alzheimer’s treatments. One seeks to dampen the impact of the most common Alzheimer’s risk gene; the other aims to decrease production of a toxic protein in the brain. AMSTERDAM, July 16, 2023 /PRNewswire/ –…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.